R&D Kidney care raises its ambitions at ASN Kidney Week 2026 Following ASN Kidney Week 2026, pharmaphorum spoke with Hansa Biopharma's Maria Törnsén and Tes Pharma's Andrea Pellacani about the conference.
News Pig to human kidney transplantation hits a new milestone A pig kidney transplanted into a human patient has broken records by lasting for nine months, buying time until a human donor organ became available.
News Australia first for Hansa’s Idefirix in commercial kidney tr... Hansa has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
News AZ forges ever-closer ties with China's CSPC Pharma AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new $1.77bn agreement to develop drugs for kidney diseases.
Patients The forgotten few: Why the kidney transplant system is faili... While innovation has reshaped therapeutic areas like oncology, transplant medicine has, by comparison, stood still.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.